share_log

Peeling Back The Layers: Exploring Health Catalyst Through Analyst Insights

Benzinga ·  May 22 04:00

8 analysts have expressed a variety of opinions on Health Catalyst (NASDAQ:HCAT) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings26000
Last 30D10000
1M Ago01000
2M Ago01000
3M Ago14000

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $12.75, a high estimate of $16.00, and a low estimate of $10.00. Observing a downward trend, the current average is 0.62% lower than the prior average price target of $12.83.

price target chart

Breaking Down Analyst Ratings: A Detailed Examination

A comprehensive...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment